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two groups as 62 nondiabetic and 51 diabetic patients, Simvastatin 10 mg/d was given 
for 24 weeks. Fasting glucose (FG), glycohemoglobin (HbAlc) fasting insulin (FI), total 
cholesterol (total-c), high density lipoprotein-cholesterol (HDL-c), triglyceride and low 
density lipoprotein-cholestarol (LDL-c) were measured before and after treatment. IR and 
~cf are assessed with homeostasis model assessment method (HOMA). The formulas 
are as follows; IR = FIx FG / 22.5 and I~cf = 20 x FI/FG-3.5, where FG (mmoblt) and FI 
(mU/I). 
Results: Total-c and LDL-c levels were significantly reduced in both groups. IR non-sig- 
nificantly increased in nondiabetic patients (3.33±2.1 vs 3.40±2.5; p>0.05), and non-sig- 
nificantly improved in diabetics patients (7.43±13.9 vs 5.52±5.3; p>0.05). ~cf increased 
in both groups (180±100 vs 241±165; p<0.005 and 62±69 vs 106±90; p<0.005) respec- 
tively. In order to rule out possible positive effects of antidiabetic therapy, results of 31 
diabetic patients whose oral antidiabetic drug (dAD) doses are increased (group I) com- 
pared with 82 patients who are use only simvastatin or dAD doses were not changed 
(group II). Total -c and LDL -c levels reduced in both groups. IR changed with treatment 
from 3.55 ±3.3 to 3.67±3.4; p<0.0005 in group I and from 9.50±17.1 to 6.20±5.7; 
p<0.0005 in group II, respectively. No correlations were found between change in IR with 
changes in total-c, LDL-c and triglyceride levels. 
Conclusion: Simvastatin treatment has neither negative nor positive effects on IR and 
has positive effect on ~cf in diabetic and non-diabetic hypercholesterolemic patients. 
1059-76 Simvastatin Lowers C-Reactive Protein by 14 Days: An 
Effect Independent of That on LDL Cholesterol 
Julie K. Plsnoe. Kathleen M. Well, Gary Grunwald, Jed Forster, Paul Poirier, Robert H, 
Eckel, The University of Colorado Health Sciences Center, Denver, Colorado. 
Introduction: Highly sensitive C-Reactive Protein (hsCRP) is an independent predictor of 
myocardial infarction. HMG Co-A reductase inhibitors (statins) decrease hsCRP levels 
over time. The early response of hsCRP to statins is unknown. The aims of this study 
were: 1) to determine the rate at which hsCRP levels change after initiation of simvasta- 
tin, and 2) to determine whether changes in hsCRP levels occur independently of change 
in LDL. 
Methods: Cross-over, double-blind study of 40 subjects with elevated LDL. Subjects were 
randomly assigned to one of two groups: (A) simvastatin followed by placebo or (B) pla- 
cebo followed by simvastatin (each for 14 days). HsCRP levels were measured on days 
0, 1, 3, 7, and 14. Levels of acute phase reactants lipoprctein(a) (Lp(a)) and fibrinogen 
were also measured. Fasting LDL was calculated at baseline, day 7 and day 14. 
Results: Baseline levels of hsCRP were not significantly different between groups A and 
B (group A Iog(hsCRP) = 0.83+/-0.15 [mean +/- SEM] versus group B Iog(hsCRP) = 0.72 
+/- 0.15 (p=0.34)). Baseline LDL levels were similar (163 +/- 44 in group A and 166 +/- 38 
in Group B), After initiation of simvastatin mean Iog(hsCRP) fell to 0.71 +/- 0.15 at day 7 
(p=0.57) and to 0.52 +/- 0.15 at day 14 (p=0.0tl). LDL cholesterol fell with simvastatin 
treatment (108 +/- 31at day 7 vs. 98 +/- 31 at day 14). By repeated measures ANOVA, 
there was a significant treatment-time effect of simvastatin on hsCRP over 14 
days(F=2.50, p=0.011 ). This effect was not seen with placebo. There was no correlation 
between treatment-ralatad change in LDL and change in hsCRP. Fibrinogen levels did 
not change significantly, Lp(a) increased slightly (p=0.03). 
Conclusions: While recent studies have shown that statins decrease hsCRP over the 
long term, this is the first study to show that the effect of simvastatin on hsCRP occurs 
early in the treatment course. The effect on LDL cholesterol occurs even earlier (7 days) 
than the fall in hsCRP (14 days), but the change in hsCRP is independent of the change 
in LDL cholesterol. In addition, this early effect on hsCRP appears to occur indepen- 
dently of changes in other acute phase reactants. 
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1080-82 Activity of Endothelin-1 Is Increased in the Forearm 
Resistance Vessels of Subjects With Hypertension 
Aniu Nohria. Leslie Garratt, Wendy Johnson, Scott Kinlay, Peter Ganz, Mark A. Creager, 
Brigham and Women's Hospital, Boston, Massachusetts. 
Background: Endothelin-1 (ET-t) is a potent vasoconstrictor peptide produced by 
endothelial cells. ET-1 has been postulated to increase vasoconstrictor tone in subjects 
at risk for atherosclerosis, particularly those with hypertension. Vasoconstriction to ET-1 
is mediated principally by the endothelin A (ETA) receptor on vascular smooth muscle 
ceils. Accordingly, we used an ET A specific antagonist, BQ-123 to test the hypothesis 
that ET-1 increases vascular resistance selectively in subjects with hypertension com- 
pared to people with other risk factors. 
Methods: BQ-123 was infused at 100 nmol/min for 80 minutes into the brachial artery of 
10 subjects whose only risk factor was hypertension (mean arterial pressure = 106-+ 15; 
mean+SD), 12 subjects with only dyslipidemia (total cholesterol = 273-+22 mg/dl), 10 
active smokers (32-+15 pack years), and 11 healthy, age-matched controls. None of the 
subjects had clinica~ evidence of atherosclerosis. Forearm blood flow (FBF) was mea- 
sured by venous occlusion plethysmogrephy. 
Results: BQ-123 induced significant vasodilatation in the hypertensive subjects com- 
pared to controls. FBF increased by 38% from 2.1:~0.7 to 2.9!-_1.2 ml/dl/min (p<0.05). 
FBF did not change in response to BQ-123 in subjects with dyslipidemia, smokers or 
healthy controls. Similarly, BQ-123 reduced forearm vascular resistance only in hyper- 
tensive subjects (from 55.9+19.8 to 40.4+13.9 mm Hg per ml/dl/min). 
Conclusion: ET-1, acting via the ET A receptor, increases the tone of resistance vessels 
in subjects with hypertension, but not In subjects with dyslipidemia or smokers. These 
results indicate that endothelin contributes to the pathophysiology of hypertension. 
Endothelin antagonists may be beneficial for the treatment of hypertension, but not for 
vascular dysfunction associated with other risk factors for atherosclerosis. 
1080-83 Heine Oxygenase Antagonism Inhibits Endothelium- 
Dependent Vseodllation in the Normal Human Forearm 
Circulation 
Julian P. Halcox. Rita Mincemoyer, Gloria Zatos, Arshed A. Quyyumi, NHLBI, Bethesda, 
Maryland. 
Background: Carbon monoxide (CO) mediates smooth muscle relaxation via generation 
of cyclic GMP in a manner analagous to nitric oxide. CO is generated from heme in 
endothelial cells by the constitutive enzymatic action of hems oxygenase. We hypothe- 
sized that endogenous CO contributes to endothelium-dependent vasomotor function in 
the human forearm circulation. 
Methods: In 5 healthy volunteers, we studied the effect of the heme oxygenase inhibitor 
tin mesoporphyrin (SNMP, 112.5nmol/min) on endothelium-dependent forearm vasodila- 
tion by acetylcholine (7.5 - 30 p.g/min). In a further 10 healthy subjects, the effect of 
SNMP on the response to ecetylcholine was also determined during inhibition of nitric 
oxide synthase and cyclooxygenase by L-NMMA (4~mol/min) and aspinn (lg by mouth), 
respectively. Sodium nitroprusside (1.6-6.4 ~g/min) was also administered before and 
after SNMP to test endothelium-independent function. Drugs were infused into the bra- 
chial artery and forearm blood flow (FBF) and vascular resistance (FVR) were measured 
by plethysmography. 
Results: SNMP did not affect basal forearm vasomotor tone or the dose response curve 
to acetylcholine. When the study was performed during co-administration of L-NMMA 
and aspirin, basal FBF and FVR were also unchanged after SNMP. However, the FBF 
and FVR dose response curves with acetylcholine (ANOVA p=0.025 and p=0.026, 
respectively), but not with sodium nitroprusside (ANOVA p=0.22 and p=0.29 respec- 
tively) were attenuated after SNMP; thus FVR was 21% greater at the peak dose of ace- 
tylcholine after SNMP. 
Conclusions: Our findings suggest that inhibition of hems oxygenase attenuates endct- 
helium-dependent but not -independent vasodilation in the normal human forearm 
microvasculature after inhibition of nitric oxide and prostanglandin synthesis. Thus, CO 
may contribute to endothelium-dependent vasodilation in conditions characterized by 
reduced nitric oxide bioavailability. 
1080-84 Endothelial Dysfunction Accelerates Hypertensive 
Evolution 
Tatsuaki Murakami. Yoshiyuki Arei, Fukui Cardiovascular Center, Fukui, Japan. 
Background: Although hypertension has great impact to develop cardiovascular dis- 
eases, evolutional mechanism of hypertension remains partially clarified. On the other 
hand, endothelial dysfunction (ED) is thought o affect atherogenic processes, there has 
been little clinical evidence for the relationship between clinical manifestation of cardio- 
vascular disease and ED. This study investigated whether noninvasively evaluated ED 
has clinical influences on hypertensive evolution (HTE). Methods: Vasomotor dysfunc- 
tion was graded by noninvasively measured reactive changes in lumen diameter of right 
brachial artery following transient occlusion for 5 minutes (FMD; flow-mediated endothe- 
lium-dependent vasodilation), and after sublingual administration of (300p.g) glyceril tdni- 
trate (TNG; endothelium-indepeodent vasodilation) using high resolution 
ultrasonography in consecutive 365 ambulatory patients who underwent he above vaso- 
motor function tests. The enrolled patients were categorized into three groups according 
to the values of FMD and TNG, and their blood pressure was followed-up for no less than 
36 months. We prospectively followed-up HTE defined as more than two stage upgrade 
of hypertension defined by world health organization or new administration of an antihy- 
pertensive agent. Results: For a mean follow-up period of 54 months (range; 36 to 73) 
with 100% follow-up, the patients with severe endothelial dysfunction (FMD<4%; Group- 
L, n=121), more frequently manifested HTE [Group-L versus Group-M with mild endothe- 
lial dysfunction (4%_<FMD<8%, n=121) plus Group-H with preserved endothelial function 
(FMD 8% or more, n=123): 28 (23.1%) versus 12 (9.9%) plus 5(4.2%), p<0.001, by 
Kaplan-Meier analysis]. There was no significant association between TNG and HTE. 
Cox proportional hazard model analysis showed that severe endothelial dysfunction 
(odds ratio=3.29, 95%confidential interval; 1.57-7.28, p<0.0t) was independently associ- 
ated with future HTE. Conclusion: These results suggest noninvasive ultrasonic evalu- 
ated endothelial dysfunction is a great practical predictor for future hypertensive 
evolution. 
1080-85 Phys ica l  Ac t iv i ty  in Pat ients  With Coronary  Ar tery  
Disease: Effects on Endothelial Function and NAD(P)H 
Oxidase-Expression 
Rainer Hambrecht, Sandra Erbs, Volker Adams, Yves Baither, Nicolle Kr~inkel, Yanwen 
Shu, Silke Krabbes, Jan F. Gummert, Friedrich W. Mohr, Gerhard Schuier, University of 
Leipzig - Heart Center, Leipzig, Germany. 
For patients (pts) with coronary artery disease (CAD), coronary endothelial function, and 
particularly nitric oxide-mediated vasodilation are clearly enhanced by physical exercise 
training (ET), The molecular basis for this improvement is still unclear. To address this 
issue we examined the effect of ET on endothelial function of the left internal mammadal 
artery (LIMA) in vivo and in vitro and determined whether ET affects the expression level 
of the subunit gp91phox of the NAD(P)H oxidase, which is known to play an important 
roJe in 02-, formation. 
Thirty-two symptomatic pts with CAD, who were scheduled for elective coronary artery 
JACC March 6, 2002 ABSTRACTS - Hypertension, Vascular Disease, and Prevention 223A 
bypass surgery (CABG) were randomized into either a training (T) or an inactive control 
(C) group. At study begin (B) and after 4 weeks (4 wks) average peak velocity in 
response to different dosages of acatylcholine (Ach) was measured invasively using 
Doppler velocimetry, vessel diameter of the LIMA was determined by quantitative angiog- 
raphy. LIMA rings not used for bypass grafting during CABG were removed and sus- 
pended in an organ chamber to determine endothelial function in vitro. Additionally, 
expression of the subunit gp91phox of the NAD(P)H oxidase was measured in samples 
of the LIMA by real time PCR and expressed as ratio over van Willebrand factor. 
ET was associated with a clear increase in APV at the highest dosage of Ach (7.2 rag/ 
min) from 47±5% to 91±10% (p<0.05 vs. C). In vitro the concentration of Ach which was 
necessary to induce 50% relaxation lED50) of the preconstricted LIMA rings was signifi- 
cantly lower in T as compared to C (7.49±0.10 [-log mol/L Ach] vs. 6.82±0.10 [-log mol/L 
Ach}, p<0.05). A considerable reduction of the NAD(P)H oxidase subunit gp91phox 
mRNA expression was observed in T as compared to C (0.47±0.15 vs 1,93±0.60 
arb.units; p<0.05). 
Conclusions: In patients with CAD regular exercise training is associated with an 
enhanced endothelial function in vivo and in vitro. The improvement of endothelial func- 
tion due to ET is paralleled by an attenuated mRNA expression of the subunit gp91phox 
of the NAD(P)H oxidase. These results imply that ET exerts its beneficial effects on the 
endothelial level at least partially by an attenuation of local oxidative stress. 
1080-86 Does Folic Acid Supplementation Improve Endothel ia l  
Function in Coronary Patients Independent of 
Homocysteine Lowering? 
Kam S. Woo, Ping Chook, Qiao Mu, Anna Chan, Wilson Chan, John E. Sanderson, 
David S. Celermajer, The Chinese University of Hong Kong, Hong Kong, Hong Kong. 
Hyperhomocysteinemia is an emerging risk factor for arterial endothelial dysfunction in 
coronary patients (CAD), which can be improved with folic acid supplementation (FA). To 
evaluate whether FA could improve endothelial function independent of homocysteine- 
lowering, 37 CAD with high homocysteine (total fasting homocysteine >12~moVI)(HHC) 
and 39 CAD with normal homocysteine (Normal HC) were studied. FA (5rag/day) or pla- 
cebo were given for 8 weeks to both groups in double blind cross over fashion, with 10 
weeks placebo-washout before crossing over, Flow-mediated dilation (endotheUum- 
dependent, FMD) were measured by high resolution ultrasound before and after each 
treatment period. The 2 groups were matched in age, gender, blood pressures, glucose, 
lipid profiles and coronary scores, but blood creatinine was slightly higher in HHC-CAD 
(108.3:~?.5.7 vs 86.1+17.61~mol/I, p<0.0001 ). FA was associated with significant reduction 
in HC and improvement of FMD in both HHC and Normal HC groups. On multivariate 
analysis, changes in folate but not homocysteine or lipid (LDL-C), baseline creatinine nor 
coronary score, were correlated to changes in FMD, (R=0.4; F value=5.5; p<0.001) 
In conclusion, folic acid supplementation has beneficial effect on endothelial function in 
coronary patients, independent of homocysteine-lowedn~. 
HIGH HC-CAD NORMAL HC-CAD 
FA Placebo FA Placebo 
LDL-C(mmol/I) 3.0±1.1 2.9±1.0 2.9±1.0 3.0±1.0 
HC (p.mol/I) 11,8±2.5" 13.6±3.0 8.8±2.1" 9,8±1.8 
Folate (l~mol/I) 83.6±10.9" 27.5±11.8 82.6±8.7* 34.0±14.7 
FMD (%) 6.1 ± 1.3** 5.4±1.8 5.9±1.6"* 4.9±1.0 
Compared with placebo : *P<0.0001 ; **P<0.005 
1080-87 Vascular  React iv i ty  and Carot id  Int imaI-Medle l  
Thickness in Children With Insulin-Dependent Diabetes 
Mellitus 
Taiinder P. Sinah. Harvey Groehn, Andris Kazmers, Wayne State University School of 
Medicine, Detroit, Michigan, Children's Hospital of MI, Detroit, Michigan. 
Background: Endothelial dysfunction is a precursor of clinically detectable atherosclero- 
sis. Diabetes mellitus is an established risk factor for atherosclerosis. Although vascular 
complications of diabetes are not clinically evident in diabetic children, the timing of onset 
of endothelial dysfunction in diabetic children is unknown, 
Objective: The objective of this study was to test the hypothesis that endothetium- depen- 
dent vasodilation is impaired in children with insulin-dependent diabetes mellitus com- 
pared to age-matched controls. 
Methods: We studied 31 diabetic teenagers (age 15.0 ± 2.4 years, duration of diabetes 
6.8 ± 3.9 years) and 29 age-matched healthy children (age 15.4 ± 2.9 years). Using high- 
resolution vascular ultrasound, we compared brachial artery responses to reactive hype- 
remia (endothelium-dependent vasodilation) and to sublingual nitroglycerine (endothe- 
lium-independent vasodilation). We also measured bilateral carotid intimal-medial 
thickness in the two groups of subjects. 
Results: There was no difference in baseline brachial artery diameter or the degree of 
reactive hyperemia between the two groups. Endothelium-depeedent vasodilation was 
significantly lower in diabetic children compared to healthy children (4.9 ± 3.4% vs. 7.9 ± 
5.8%, P = 0.02). There was no difference in endothelium-independent vasodilation (16 ± 
5% vs. 18 ± 8 %, P = NS) or mean carotid intimal-medial thickness between the groups 
(0.33 ± 0.10 vs. 0.32 ± 0.08 ram, P = NS). There was no relationship of brachial reactivity 
to the diabetic control (Hb At C) or the duration of diabetes. 
Conclusions: Endothelial function is impaired in children with diabetes mellitus within the 
first decade of its onset. Strategies to improve endothelial function in these children may 
have a therapeutic role in this high-risk group. 
1080-88 Endothe l ia l  Funct ion ,  Sk in Capi l lary  Density,  and 
Plasma Endothelln Levels in Hypertensive and 
Normotenslve Pat ients  With Ang ina l  Chest  Pain and 
Normal  Coronary  Ar ter iograma 
Tarek F, Antonios. Guilia Russo, Khaled M. Hasan, Sue J. Brown, Donald R, Singer, SL 
George's Hospital Medical School, London, United Kingdom. 
Background: Patients with anginal chest pain and normal coronary artedes (CP-NCA) 
often have abnormal endothelium-dependent vasedilator responses, reduced coronary 
blood flow reserve, and higher levels of plasma endothelin-1. We recently showed that 
skin capillary density is lower in patients with CP-NCA. 
Aims & Methods: The aim of this study was to examine the relationship between capillary 
density (measured by intra-vital microscopy before and after maximisation with venous 
congestion) and flow-mediated dilatation (FMD) measured by brachial artery Doppler 
ultrasound and plasma endothelin levels. We studied 19 patients With CP-NCA [11 were 
hypertensive (age 60yr, sitting BP on treatment 145/82mmHg) and 8 were normotensive 
(age 60yr, BP 128/75mmHg)] and 9 healthy controls (age 59yr, BP 125/78mmHg). 
Results: Mean capillary density was significantly lower in patients with CP-NCA indepen- 
dent of their BP compared to healthy controls, both at baseline [55±5 in hypertensives, 
61±3 in normotensive versus 73±4 in controls, p=0.001 ANOVA], and after maximisetion 
[60±5, 67±3 versus 85±4 respectively, p<0.0001], FMD was higher in controls than in 
normotansive CP-NCA who in turn had higher values than hypertensive CP-NCA (5,561 
versus 4,329 versus 3.646%, p--0.056. Capillary density was markedly lower with higher 
plasma endothelin-1 levels in subjects with CP-NCA (r= - 0.7, p=0.01). 
Conclusions: We confirmed a significant reduction in baseline and maximal skin capillary 
density in patients with CP-NCA independent of blood pressure. Our findings suggest 
that plasma endothelin-1 may be implicated in the pathogenesis of capillary rarefaction in 
this syndrome. 
1080-89 ACE Inh ib i tora  Improve  Endothe l ia l  Funct ion  of  
Coronary Arterioles From Pat ients  With Atherosclerosla 
by Influencing Local Kinin Release 
Chdstiane P. Tiefenbacher. Stefanie Fdeddch, "Fine Bleeke, University of Heidelberg, 
Heidelberg, Germany. 
ACE-inhibitors attenuate endothelial dysfunction by increasing the availability of NO in 
human coronary arterioles from patients with atherosclerosis. The release of NO by the 
coronary circulation is, in part, regulated by local kinin production in resistance vessels. 
We, therefore, hypothesized that the effect of ACE inhibitors on endothelial dysfunction is 
mediated via influencing local kinin metabolism. 
Methods: In isolated perfused coronary arterioles (<801~M; videomicroscopy) from atrial 
appendage of patients with and without (control) atherosclerosis, dose-responses to the 
endotheliurn-dependent agonists histamine (His), serotonin (5-HT) and acetylcholine 
(ACh) as well as to the endothelium-independent vasodilator sodium nitroprusside (SNP) 
were obtained under control conditions and following incubation with the ACE-inhibitor 
lisinopril (lisi; 10-5M) alone or in combination with L-NAME (NO-inhibitor), HOE 140 
(bradykinin B2-receptor antagonist) or dichloroisocoumarin (DCI; blocker of kinin-forming 
enzymes). 
Results: In control vessels (n=6), there was maximal vasodilation to His and SNP 
(96±6% and 97±8%, respectively), a diverse effect of 5-HT (19±19%) and predominantly 
vasoconstriction to ACh (-15±21%). Lisi, HOE and DCI did not significantly influence the 
effects of the different agonists. In atherosclerotic vessels (n=6), the vasodilatory effect of 
His was significantly (p<0.05) attenuated (80±2%), 5-HT caused vasoconstriction (- 
20±10%) and constriction to ACh was increased (-27 ±25%), whereas the effect of SNP 
was unaltered (100±3%). Lisi significantly improved the vasodilatory effect of His 
(98±4%) and diminished constriction to 5-HT and ACh (3±11% and -20±18%, respec- 
tively) without altaring the response to SNP (100±1%). Co-treatment with L-NAME, HOE 
or DCI attenuated the effect of lisL 
Conclusions: These results indi~ata that in coronary arterioles from patients with athero- 
sclerosis, treatment with lisinopril acutely increases the effects of endothelial vasodila- 
tors. ACE-inhibitors improve endothelial dysfunction in coronary resistance vessels via 
activation of local kinin production. 
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1081-77 Augmented Gene Transfer in Lungs From Pat ients  With 
Scleroderma 
Hunter C. Champion. John V. Conte, David Kass, Fred Wigley, Johns Hopkins Hospital, 
Baltimore, Maryland. 
The goal of this study was to examine the potential differences in the expression of ade- 
novirus-mediated gene transfer to pulmonary arteries from patients with scleroderma and 
normal donor pulmonary arteries. We used 2 different adenoviral vectors, driven by a 
CMV promoter. Pulmonary arteries were removed from exptanted lungs and cut into 
rings. The artedes were incubated with an adenoviral vector that expresses the reporter 
gene (beta-galactosidase or endothelial nitric oxide synthase (eNOS). Arteries were 
incubated with virus for 2 hours, and then incubated in medium for 24 hours to allow 
